1À3 Impaired DA signaling has been linked to a number of neurodegenerative and psychiatric disorders such as attention-deficit hyperactivity disorder (ADHD), bipolar disorder, major depression, Tourette's syndrome, Parkinson's disease, and schizophrenia. 4À8 The synaptic DA concentration influences postsynaptic DA signal transduction capacity and is modulated by the activity of a presynaptic D 2 DA receptor, that modulates DA release, and the DA transporter (DAT), 1,9 that clears DA to achieve DA inactivation and recycling.
T he neurotransmitter dopamine (DA) modulates a variety of physiological functions and behavioral responses including attention, arousal, cognition, reward, and motor activity in the central nervous system (Figure 1 ). 1À3 Impaired DA signaling has been linked to a number of neurodegenerative and psychiatric disorders such as attention-deficit hyperactivity disorder (ADHD), bipolar disorder, major depression, Tourette's syndrome, Parkinson's disease, and schizophrenia. 4À8 The synaptic DA concentration influences postsynaptic DA signal transduction capacity and is modulated by the activity of a presynaptic D 2 DA receptor, that modulates DA release, and the DA transporter (DAT), 1, 9 that clears DA to achieve DA inactivation and recycling. 10 DAT (SLC6A3) is a member of a family of Na þ -coupled solute transporters whose substrates include neurotransmitters, nutrients, osmolytes, and amino acids. Several reports have demonstrated that experimental DAT deficiency results in pronounced changes in dopaminergic tone and locomotor hyperactivity. 10À12 In addition, DAT is the primary target for widely used psychostimulants, such as amphetamine and cocaine that acutely elevate synaptic DA concentrations. Cocaine is a competitive DAT inhibitor and attenuates DA clearance by occupying the DA binding site on DAT, whereas amphetamine promotes DAT-mediated DA efflux that also results in the increased DA synaptic concentration. 13 DAT activity has also been demonstrated to be a subject of acute, dynamic regulation by several post-translational mechanisms, such as constitutive endocytosis, protein-kinase-C (PKC)-dependent internalization, proteinÀprotein interactions, and substrate-induced changes in surface expression level. 13, 14 The spatial organization and temporal control of these mechanisms remain largely unknown and, when disrupted, may influence risk for disorders linked to compromised DA signaling.
The investigation of DAT regulation has thus far trailed similar efforts directed at membrane receptors and channels due a number of important challenges. First, the lack of an efficient antibody against an extracellular epitope does not allow direct localization and visualization of DAT molecules in living cells without prior chemical processing (fixation and permeabilization). 15, 16 Second, the use of popular fusion tags, such as green fluorescent protein (GFP) and hemagglutinin (HA), requires genetic perturbation of DAT and thus does not allow direct visualization of endogenous DAT. Third, traditional autoradiographic, biochemical, and optical techniques to monitor DAT expression, function, and cellular distribution suffer from suboptimal spatial and temporal resolution and are limited to providing ensemble-averaged information. 17, 18 Recently, a series of dyeconjugated fluorescent cocaine analogues has been developed and successfully used to directly visualize DAT in living cells for the first time. Cha, Eriksen and colleagues used an organic dyeconjugated 2β-carbomethoxy-3β-(3,4-dichlorophenyl)tropane (RTI 111) ligand to visualize changes in DAT cellular movement in response to different stimuli via laser confocal microscopy. 16 However, this ligand does not have the photostability properties to permit single-molecule resolution.
We have focused on developing new DAT-specific ligands for conjugation with nanometer-sized semiconductor nanocrystals, known as quantum dots (Qdots). Qdots offer several distinct advantages over conventional fluorophores and permit visualization of membrane-associated proteins with high accuracy and temporal resolution, with reported values as low as 10 nm with 10 ms integration time.
19À23 Specifically, their excellent brightness and superior resistance to photodegradation enable noninvasive imaging of complex biological processes with high signal-to-noise ratio (SNR) over time scales from milliseconds to hours. Also, the broad absorption spectra and size-dependent, narrow, symmetric emission spectra of Qdots considerably simplify multiplexed, molecular imaging experiments. We have previously reported the synthesis of GBR12909-and GBR12935-based DAT-specific ligands for conjugation with Qdots. 24, 25 In this effort, we sought to improve the design of the DAT ligand by incorporating a phenyltropane-based dopamine reuptake inhibitor parent compound (β-CFT, WIN 35,428) into the structure. β-CFT is a structural analogue of cocaine, is 3À10Â more potent than cocaine, and is characterized by excellent structural stability. 26, 27 Our choice of the parent compound is also validated by multiple instances of the use of radiolabeled β-CFT to map DAT distribution in the animal and human brain.
28À31
Here, we present a relatively simple and rapid approach for Qdot-based direct visualization of DAT in living cells that uses a DAT-specific, biotinylated 2-β-carbomethoxy-3-β-(4-fluorophenyl)-tropane (IDT444) in conjunction with streptavidin-conjugated Qdots (SavQdots). Using this approach, we demonstrate the specificity of DAT Qdot labeling and the ability to detect DAT-expressing mammalian cells at a combination of low nanomolar concentrations of IDT444 and picomolar concentrations of Qdots. To determine whether we could use our Qdot-based approach to capture DAT trafficking, we visualized acute, PKCdependent internalization of DAT-Qdot complexes in response to phorbol ester treatment. Finally, we show the advantages of Qdot photophysical properties in time-lapse image series acquisition over extended periods of time.
' RESULTS AND DISCUSSION Cocaine Analogue Synthesis. To develop a DAT-specific probe, a biotinylated cocaine analogue IDT444 (6) was synthesized ( Figure 2A ). The IDT444 ligand is composed of four distinct parts: (i) a high-affinity cocaine analogue, 2-β-carbomethoxy-3-β-(4-fluorophenyl)tropane (β-CFT or WIN 35,428), first reported by Clarke et al., (ii) a short alkyl spacer, (iii) a poly(ethylene glycol) (PEG) chain (average MW 5000), and (iv) a biotin terminus ( Figure 2B ). 26 β-CFT was chosen as the parent drug due to its high affinity for DAT, excellent structural stability, and pharmacological properties closely resembling those of cocaine. 26, 27 The hydrophobic alkyl linker was incorporated into the IDT444 ligand by attaching it to the nitrogen atom on the tropane ring. The tropane nitrogen was chosen as the attachment point based on previous studies, which showed that bulky groups attached to the tropane N-position had no significant effect on the phenyl tropane pharmacological properties and structural stability. 27À31 The short alkyl spacer was attached to the tropane nitrogen to increase flexibility and allow enhanced access to the binding site. The PEG chain was used to ensure the IDT444 ligand is soluble in aqueous buffers and possibly reduce any potential nonspecific interactions with the cellular membrane. 32 The biotin handle at the end of the PEG chain served as a binding site for SavQdots. Detailed synthetic steps are described in the Supporting Information.
DAT Visualization in Flp-In-293 Cells in Suspension. The HEK Flp-In-293 cell line was used as a model stable expression system to investigate the interactions of our Qdot-based fluorescent probes with DAT. To achieve DAT expression, a plasmid vector containing the FRT site linked to the hygromycin resistance gene and the DAT cDNA was integrated into the genome via Flp recombinase-mediated DNA recombination at the FRT site. DAT-expressing Flp-In-293 cells were selected in the presence of 100 μg/mL hygromycin B.
DAT-Flp-In-293 cells were subjected to a two-step solutionbased Qdot labeling protocol. Flp-In-293 cells were incubated with the IDT444 ligand and subsequently labeled with SavQdots in solution to prevent the loss of cells due to detachment from the plate surface, reduce nonspecific Qdot interactions with the culture vessel, and enhance specific recognition of the biotinylated ligand. These cells were incubated with 100 nM IDT444 phosphate-buffered saline (PBS) solution for 5 min at 37°C, lifted off the culture plate by gentle pipetting, centrifuged, and resuspended in 1 nM SavQdot PBS solution for 5 min at 4°C. After several wash steps to rinse away the unbound ligands and conjugates, specific DAT Qdot labeling was demonstrated by confocal microscopy and flow cytometry, which were used as complementary techniques to quantify DAT Qdot labeling. Representative flow cytometry histograms and confocal images of the specific labeling of DAT expressed in hDAT-Flp-In-293 cells are shown in Figure 3 . DAT-Flp-In-293 cells pretreated with 1 μM GBR12909, a high-affinity DAT antagonist, and DAT-FlpIn-293 cells incubated with 1 nM SavQDs only were used as control cell populations. 33, 34 Compared to the control samples, the prominent increase of the median fluorescence intensity (MFI) as assessed by flow cytometry ( Figure 3A3 ) and the presence of membrane-associated uniform fluorescent halos on the acquired confocal images ( Figure 3A1ÀA2 ) indicated successful, specific hDAT Qdot labeling. GBR12909 effectively blocked the interaction of SavQdot-IDT444 conjugates with hDAT ( Figure 3B1ÀB3 ), and the cell population exposed to SavQdots only ( Figure 3C1ÀC3 ) had similarly low percentage of labeled cells as observed for the preblocked cell population, indicating minimal ligand nonspecific binding. The images and flow cytometry histograms shown in Figure 3 are representative of at least five independent experiments. IDT444 and SavQdot Dose Response. Next, we investigated the sensitivity of flow cytometric detection of DAT-Flp-In-293 cells using our Qdot-based approach. In the first series of doseÀresponse experiments, the SavQdot concentration was kept constant at 1 nM, and IDT444 concentration was varied over several orders of magnitude (10 pM to 1 μM). The cell populations were subjected to the two-step labeling protocol described above and analyzed by flow cytometry. Parallel DATFlp-In-293 cells that were preblocked with 1 μM GBR12909 were used as a control to assess ligand nonspecific binding at different IDT444 concentrations. The IDT444 concentrationÀresponse curves are shown for both cell populations in Figure 4A . Each data point represents the averaged MFI from three independent experiments. Robust standard deviation (rSD) was calculated from the MFI and the robust coefficient of variation (rCV) of the fluorescence intensity distribution (see the Supporting Information). We observed statistically significant difference in MFI of labeled and control DAT-Flp-In-293 at the IDT444 concentration of 1 nM (p < 0.05). Also, it is apparent from the control population MFI curve that the increase of IDT444 concentration over several orders of magnitude does not result in significant ligand-mediated nonspecific binding. This suggests that DAT detection in Flp-In-293 cells is ligand-specific and dose-dependent. In the second series of doseÀresponse experiments, IDT444 concentration was kept constant at 100 nM, and SavQdot concentration was varied over several orders of magnitude (10 pM to 10 nM). Parallel DAT-Flp-In-293 cells preblocked with 1 μM GBR12909 were used as a control to assess Qdot nonspecific binding at different concentrations. We observed statistically significant difference in MFI of labeled and control DAT-Flp-In-293 at SavQdot concentration as low as 100 pM (p < 0.05, Figure 4B ). It should be noted that the MFI of the control population increased significantly with the increasing SavQdot dose. This indicates that one must carefully optimize the concentration of Qdots to be used in our approach, since the SNR will be dependent on the Qdot surface chemistry as well as cell type. 32 Here, we determined that we could successfully detect Flp-In-293 cells stably expressing DAT at a combination of low nanomolar concentrations of IDT444 and picomolar concentrations of SavQdots.
DAT Visualization in HeLa Cells in Situ. After we successfully demonstrated specific Qdot labeling of DAT in stably transfected Figure 6B1,B2 ). This experiment demonstrates the applicability and utility of our Qdot-based labeling approach in the investigation of DAT regulation in living cells.
Qdot Photostability. To demonstrate that our Qdot-based labeling approach can be used as a tool to visualize DAT over extended periods of time, we compared SavQdots to a standard organic dye FITC. Individual 8-bit images (512 Â 512 pixels, 1 Airy unit) were acquired every 30 s for 10 min at a scan speed of 51.20 μs/pixel, with laser intensity set to 20% ( Figure 7A ). Fluorescence intensity of Qdot or FITC DAT membrane labeling in Flp-In-293 cells was quantified, normalized, and plotted as a function of acquisition time ( Figure 7B ). Each data point represents average integrated membrane fluorescence intensity for 6 cells from two independent experiments. In the case of FITC, bleaching occurs within 300 s (I norm < 0.2), whereas the intensity of Qdot labeling undergoes minimal decrease within 600 s. The photobleaching issue becomes important when one is monitoring biological processes for longer periods of time at high temporal resolution. Excellent photostability of Qdots makes our Qdot-based labeling approach an excellent candidate for monitoring changes in DAT surface expression level and cellular localization for prolonged periods of time at temporal resolution higher than that allowed by the use of traditional fluorophores.
' CONCLUSION
To summarize, our goal for the current effort was to develop a DAT-specific ligand and demonstrate specific labeling of cell surface DAT using Qdot-based detection. The biotinylated derivative of the β-CFT cocaine analogue, IDT444, was prepared by attaching the biotin-PEG-alkyl group to the tropane nitrogen. The ability to visualize mammalian cells stably expressing DAT with SavQdot-IDT444 conjugates was clearly demonstrated by flow cytometry and confocal microscopy for Flp-In-293 cells in suspension and HeLa cells in situ. We determined that DATexpressing cells can be detected using a combination of low nanomolar concentrations of IDT444 and picomolar concentrations of SavQdots, as assessed by flow cytometry. The relatively high sensitivity of our approach in combination with short sample preparation time renders IDT444 useful in a quantum-dot-based fluorescent assay to monitor DAT expression, function, cellular distribution, and regulation. Specifically, we demonstrated the applicability and utility of our approach in the visualization of acute, PKC-dependent DAT internalization. Due to its sensitivity and flexibility, the quantum dot-based fluorescent assay platform we describe can potentially replace conventional biochemical and radiolabeled isotope-based approaches to study the distribution and regulation of DAT proteins, and may also be useful in highthroughput screening of novel DAT modulators. If issues related to blood-brain barrier penetration of Qdots can be overcome, it is not unreasonable to consider whether our approach might not also be of diagnostic utility for perturbations of in vivo DAT levels in addiction, neuropsychiatric, or neurodegenerative disorders. Finally, our Qdot-based approch should allow appropriation of the unique photophysical properties of Qdots to achieve time-lapse imaging of single DAT molecules in living cells for prolonged periods of time combined with improved temporal resolution, providing new opportunities to elucidate the molecular mechanisms supporting DAT regulation.
' METHODS
Materials. All reagents were purchased from VWR or Sigma-Aldrich and used without further purification unless otherwise noted. Analytical TLC was performed on commercial plates obtained from Sorbent Technologies (Atlanta, GA) coated with silica gel with a UV indicator (cat. no. 1634126), and spots were located by UV light (254 and 365 nm). Silica gel for flash chromatography was obtained from Sorbent Technologies (60 Å, 230À400 mesh). Biotinylated PEG5000 NHS ester was obtained from Laysan Bio (Arab, AL). Streptavidin-conjugated quantum dots with a maximum fluorescence emission at 655 nm (SavQdots655) were obtained as a 1 μM solution dissolved in borate buffer at pH 8.5 from Invitrogen (Carlsbad, CA). GBR12909 was obtained from Tocris Bioscience (Ellisville, MI). Streptavidin-conjugated fluorescein isothiocyanate (SavFITC) was purchased from Invitrogen (Carlsbad, CA).
Ligand Synthesis. A mixture of the diastereoisomers (1a) and (1b) was synthesized from tropanone using the method described by Meltzer et al., and these were demethylated with R-chloroethyl chloroformate to give a mixture of the boat (2a) and the chair (2b) in 87% yield (Figure 2A) . 28 According to Meltzer et al., cocaine analogues (1a) and (1b) both exhibited low nanomolar affinity for DAT; therefore, the biotin-terminated linker arm was attached to both diastereoisomers in the following manner. The alkyl spacer was then attached to the mixture of diastereoisomers (2a) and (2b) by refluxing overnight in acetonitrile with the phthalimide protected alkyl spacer (3) in the presence of potassium carbonate and potassium iodide. This gave the mixture of diasterioisomers (4a) and (4b). Compound (3) was synthesized as previously described by Tomlinson et al. 39 The pthalimide protecting group was removed from (4a) and (4b) by stirring a solution of the desired compound in the presence hydrazine mono hydrate to yield the mixtures (5a) and (5b). The final intermediate was conjugated to biotinylated PEG-NHS ester by stirring a solution of the mixture of diastereoisomers of phenyl tropane attached to the amino terminated alkyl spacer with biotinylated PEG5000-NHS in methylene chloride for 24 h. The solution was then evaporated, and the product was washed with diethyl ether to give IDT444 (6) . The product was further purified from excess unreacted intermediate (5a,b) by size-exclusion chromatography using PD-10 column (GE Biosciences). The final product was characterized by MALDI-TOF mass spectrometry (Supporting Information Figure S1 ). Detailed synthetic steps are described in the Supporting Information.
Cell Line Maintenance. The Flp-In 293 host cell line (Invitrogen) was grown in complete medium (D-MEM with 2 mM L-glutamine, 10% FBS, 1% pen/strep) supplemented with 100 μg/mL Hygromycin B in a 37°C incubator with 5% CO 2 . The wild-type human DAT (hDAT) cDNA cloned in the pcDNA5/FRT expression vector was transfected into Flp-In-293 cells using the Fugene 6 transfection reagent (Roche, NJ). After 48 h recovery, the cells were grown in medium with 100 μg/mL hygromycin B (100 μg/mL) added for several weeks to select for resistant cells where the cDNA construct had been recombined into the Flow Cytometry. Qdot-labeled cells were analyzed on a BD LSRII flow cytometer (BD Biosciences). Qdot655 fluorescence was detected with the 488 nm excitation laser on the FL3 channel (640 nm long pass filter). Forward (FSC) and side scatter (SSC) data were collected in linear mode, while the FL3 channel data was collected in log mode. Twenty thousand events were collected per sample. FSC and SSC measurements were used to gate the viable cell region to assay for Qdot fluorescence (Supporting Information Figure S2 ). Median fluorescence intensity (MFI) and robust standard deviation (rSD) were then determined for the gated cell population using Flow Jo (Tree Star, Ashland, OR). See the Supporting Information for detailed explanation of the statistical analysis in Flow Jo.
Confocal Microscopy (Suspended Cells). Flow cytometry cell samples were also used for confocal image acquisition. A 50 μL aliquot of the suspended cells was transferred onto the 0.13À0.17 mm thin microscope cover glass. DIC and fluorescent images were acquired on the Zeiss LSM 510 inverted confocal microscope with the 488 nm excitation laser, a 650 nm long pass filter (SavQdot655) or a 505À550 nm band-pass filter (SavFITC), and Zeiss Plan-Apo oil immersion objective (63Â, NA 1.40).
Confocal Microscopy (Adherent Cells). HeLa cells were seeded in 8-well chamber slides (Nalge Nunc, Rochester, NY) and transiently transfected as described above. Prior to confocal confocal microscopy, the old medium was aspirated from the chamber slide wells, and HeLa cells were washed 3Â with warm imaging buffer (Phenol Redfree DMEM/5%FBS). HeLa cells were then incubated with 100 nM IDT444, washed 3Â with warm imaging buffer, incubated with 1 nM SavQdot655, washed 3Â with warm imaging buffer, and visualized in 200 μL of warm imaging buffer at 37°C. DIC and fluorescent images were acquired on the Zeiss LSM 510 inverted confocal microscope with the 488 nm excitation laser, a 650 nm long pass filter, and Zeiss Plan-Apo oil immersion objective (63Â, NA 1.40).
Qdot versus FITC Photostability. DAT-Flp-In-293 cells were incubated with 100 nM IDT444 and resuspended in either 1 nM SavQdot or 10 μg/mL SavFITC. The time-lapse image series were acquired on the Zeiss LSM 510 inverted confocal microscope with the 488 nm excitation laser, a 650 nm long pass filter (Qdot) or a 505À550 nm band-pass filter (FITC), and Zeiss Plan-Apo oil immersion objective (63Â, NA 1.40). Images (512 Â 512 pixels, 1 Airy unit) were acquired every 30 s for 10 min at a scan speed of 51.20 μs/pixel, with laser intensity set to 20%. Membrane-associated intensity was quantified for each frame by integrating fluorescence intensity over a manually drawn region encompassing the membrane area, with DIC images serving as a reference point (Metamorph). Intensity values were normalized with respect to the highest intensity value obtained (I/I 0 , where I 0 = I max ).
' ASSOCIATED CONTENT b S Supporting Information. Detailed synthetic steps and ligand characterization, flow cytometry analysis, and Qdot labeling of HeLa cells in suspension. This material is available free of charge via the Internet at http://pubs.acs.org.
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